Search Results for "Lyophilisation 6th London 2012"
Original Source: 6th Annual Lyophilisation Conference
Evaluating the future of the drying technologies for biopharmaceuticals. Strategies for successful formulation, optimised cycle development and scale up 4th - 6th September 2012, London EC1, UK
Matching Channels
Macitentan (Opsumit®) is a novel dual endothelin receptor antagonist (ERA) that resulted from a tailored drug discovery process with the target to develop an ERA optimized for efficacy and safet...
MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry. For more than two decades, the company has led the industry in developing innovative p...
In addition to the world famous Cambridge University, Cambridge and its surrounding area is a hub of globally reaching biotechnology companies. With more than 247 companies, and the high quality res...
ATX-MS-1467 for patients with multiple sclerosis (MS)
ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the...
According to the American Brain Tumor Association, just over 24,000 patients will be diagnosed with a primary malignant brain tumour during 2012 in the US alone. Some 80% of primary malignant brain...
Matching News
Lyophilisation webinars of 2012 announced by SP Scientific
SP Scientific has announced its fall 2012 program of free educational webinars delivered by industry experts on topics in Lyophilisation and Freeze Drying.
"Pharma Lyophilisation Market Will Reach $2.48 Billion in 2012" Predicts Visiongain Report
London, United Kingdom, September 13, 2012 --(PR.com)-- Visiongain predicts that pharmaceutical freeze drying revenues will increase strongly from 2012 to 2022, with many commercial opportunities for...
SMi is proud to present their inaugural conference on Lyophilisation: Freeze-drying in pharmaceuticals & Biopharmaceuticals held on the 25-26 February in London. This conference will provide the perfe...
Freeze-Drying for Pharmaceuticals and Biopharmaceuticals
SMi is proud to present their inaugural conference on Lyophilisation...
SYNERLAB makes simultaneous acquisitions
Addition of expertise in lyophilisation and galenic formulations enables SYNERLAB to offer full range of services
Façonnage : Synerlab ajoute la lyophilisation à ses services
Le secteur du façonnage pharmaceutique poursuit son mouvement de consolidation. Le groupe alsacien Synerlab…
Linde says cryogenic fog can help freeze-dry biologics
Industrial gas supplier Linde claims its 'cryogenic fog' technology is the first commercially-feasible way of controlling ice-crystal formation during the lyophilisation of biologic drugs.
A phenomenal legacy for London 2012
The London 2012 anti-doping facilities will be developed after the Olympic and Paralympic Games into a world-class resource that could help revolutionise healthcare. The MRC-NIHR Phenome Centre will...
Matching PubMed Articles
In situ lyophilisation of nifedipine directly in hard gelatine capsules.
Hydrophobic drugs present a challenge due to: (i) adhesion and agglomeration; hence the choice of the suitable processing technique to have the drugs into orally administered dosage forms is critical....
Ian Needleman: 'The spirit of positivity at London 2012 was incredible'.
Ian Needleman talks to the BDJ about his research study at the London 2012 Olympic Games, the future of periodontology and his top tips for dental students.
Highlights from the 47th EUCHEM conference on stereochemistry, Bürgenstock, Switzerland, May 2012.
Opera notes: events to look out for in 2012.
The effect of pre-treatments on the composition of Cunninghamella elegans biomass and on its biosorption yields in the treatment of simulated textile wastewaters was investigated. The inactivated biom...
